Correlates of Protection for M Protein-Based Vaccines against Group A Streptococcus

被引:27
|
作者
Tsoi, Shu Ki [1 ]
Smeesters, Pierre R. [1 ,2 ]
Frost, Hannah R. C. [1 ]
Licciardi, Paul [3 ,4 ]
Steer, Andrew C. [1 ,2 ,4 ]
机构
[1] Murdoch Childrens Res Inst, Grp A Streptococcus Res Grp, Melbourne, Vic 3052, Australia
[2] Univ Melbourne, Ctr Int Child Hlth, Melbourne, Vic 3052, Australia
[3] Murdoch Childrens Res Inst, Pneumococcal Res Grp, Melbourne, Vic 3052, Australia
[4] Royal Childrens Hosp, Dept Paediat, Melbourne, Vic 3052, Australia
关键词
PNEUMOCOCCAL CONJUGATE VACCINE; CLUSTER TYPING SYSTEM; OPSONOPHAGOCYTOSIS ASSAY; INTRANASAL IMMUNIZATION; FUNCTIONAL ANTIBODIES; MATERNAL ANTIBODY; CONSERVED REGION; T-CELL; CHALLENGE; EFFICACY;
D O I
10.1155/2015/167089
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group A streptococcus (GAS) is known to cause a broad spectrum of illness, from pharyngitis and impetigo, to autoimmune sequelae such as rheumatic heart disease, and invasive diseases. It is a significant cause of infectious disease morbidity and mortality worldwide, but no efficacious vaccine is currently available. Progress in GAS vaccine development has been hindered by a number of obstacles, including a lack of standardization in immunoassays and the need to define human correlates of protection. In this review, we have examined the current immunoassays used in both GAS and other organisms, and explored the various challenges in their implementation in order to propose potential future directions to identify a correlate of protection and facilitate the development of M protein-based vaccines, which are currently the main GAS vaccine candidates.
引用
收藏
页数:11
相关论文
共 50 条
  • [11] Vaxfectin®, a cationic lipid-based adjuvant for protein-based influenza vaccines
    Hartikka, Jukka
    Bozoukova, Vesselina
    Yang, Catherine K.
    Ye, Ming
    Rusalov, Denis
    Shlapobersky, Mark
    Vilalta, Adrian
    Wei, Qun
    Rolland, Alain
    Smith, Larry R.
    VACCINE, 2009, 27 (46) : 6399 - 6403
  • [12] Protective efficacy of group A streptococcal vaccines containing type-specific and conserved M protein epitopes
    Penfound, Thomas A.
    Chiang, Edna Y.
    Ahmed, Elwaleed A.
    Dale, James B.
    VACCINE, 2010, 28 (31) : 5017 - 5022
  • [13] Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population
    Gupta, Varun K.
    Sekhar, Sasank
    Dhanda, Vanita
    Toor, Devinder
    Kumar, Rajesh
    Chakraborti, Anuradha
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (03) : 352 - 358
  • [14] Vaxfectin: a versatile adjuvant for plasmid DNA- and protein-based vaccines
    Sullivan, Sean M.
    Doukas, John
    Hartikka, Jukka
    Smith, Larry
    Rolland, Alain
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (12) : 1433 - 1446
  • [15] Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus
    Marasini, Nirmal
    Giddam, Ashwini K.
    Ghaffar, Khairunnisa A.
    Batzloff, Michael R.
    Good, Michael F.
    Skwarczynski, Mariusz
    Toth, Istvan
    NANOMEDICINE, 2016, 11 (10) : 1223 - 1236
  • [16] Preformulation characterization of an aluminum salt-adjuvanted trivalent recombinant protein-based vaccine candidate against streptococcus pneumoniae
    Iyer, Vidyashankara
    Hu, Lei
    Liyanage, Mangala Roshan
    Esfandiary, Reza
    Reinisch, Christoph
    Meinke, Andreas
    Maisonneuve, Jeff
    Volkin, David B.
    Joshi, Sangeeta B.
    Middaugh, C. Russell
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2012, 101 (09) : 3078 - 3090
  • [17] Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines
    Stump, William H.
    Klingenberg, Hayley J.
    Ott, Amy C.
    Gonzales, Donna M.
    Burns Jr, James M.
    VACCINES, 2024, 12 (04)
  • [18] Group B Streptococcus: developing a correlate of protection for a vaccine against neonatal infections
    Dangor, Ziyaad
    Lala, Sanjay G.
    Kwatra, Gaurav
    Madhi, Shabir A.
    CURRENT OPINION IN INFECTIOUS DISEASES, 2016, 29 (03) : 262 - 267
  • [19] A dual-adjuvanting strategy for peptide-based subunit vaccines against group A Streptococcus : Lipidation and polyelectrolyte complexes
    Zhao, Lili
    Yang, Jieru
    Nahar, Ummey Jannatun
    Khalil, Zeinab G.
    Capon, Robert J.
    Hussein, Waleed M.
    Skwarczynski, Mariusz
    Toth, Istvan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (24)
  • [20] Immune Responses Elicited by Live Attenuated Influenza Vaccines as Correlates of Universal Protection against Influenza Viruses
    Jang, Yo Han
    Seong, Baik L.
    VACCINES, 2021, 9 (04)